PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

John C. McKew at NCATS, NIH to Speak at 8th Modern Drug Summit October 24-26 in Philadelphia, Pennsylvania - John C. McKew, Chief of Therapeutic Development Branch, a Division of Preclinical Innovation - GTCbio.com
John C. McKew at NCATS, NIH to Speak at 8th Modern Drug Summit October 24-26 in Philadelphia, Pennsylvania

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2012/09/24 - John C. McKew, Chief of Therapeutic Development Branch, a Division of Preclinical Innovation - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

National Center for Advancing Translational Sciences (NCATS) at NIH will give a plenary keynote presentation on “Catalyzing Innovation: The NIH National Center for Advancing Translational Sciences” at the 8th Modern Drug Discovery & Development Summit taking place on October 24-26, 2012 in Philadelphia, PA

The National Center for Advancing Translational Science (NCATS) is a newly formed center within the National Institutes of Health. It was created by merging existing programs and several new initiatives into a new center. This new center now has two main divisions: the Division of Preclinical Innovation and the Division of Clinical Innovation. In his presentation, Dr. McKew will give an overview of the new center and highlight the translational research programs contained within.

Benefits of his presentation include:
• Better understanding of the role the NIH and NCATS play in developing novel public private partnerships for therapeutic development
• Understanding of the existing and newly developed preclinical development initiatives NCATS has announced along with their solicitation timelines.
• Examples of successful collaborative projects from the Therapeutics for Rare and Neglected Diseases (TRND) and Bridging Interventional Development Gaps (BrIDGs) program portfolios.

Dr. McKew’s responsibilities include developing the Therapeutics for Rare and Neglected Disease (TRND) program and the Bridging Interventional Development Gaps program (BrIDGs; former NIH-RAID program). Both of these programs focus on novel public/private partnerships to advance collaborative drug discovery projects through pre-clinical development into early clinical development. Prior to joining the NIH, Dr. McKew held a Director level position at Wyeth Research and began his career at the Genetics Institute in Cambridge, Massachusetts where he spent a total of 17 years. His research interests include rare and neglected disease research, medicinal chemistry, synthetic methodology, and tool compounds to probe biology. These interests have resulted in >20 publications, 10 Granted US Patents and multiple podium presentations. Dr. McKew also enjoys sharing his passion for science with others. This has prompted him to become course director and lecturer in GMS PM 881 “Drug Discovery and Development” a graduate level course in the Department of Pharmacology and Experimental Therapeutics which resulted in his appointment as an Adjunct Associate Professor Boston University School of Medicine.

GTC's 8th Modern Drug Discovery and Development Summit features a plenary keynote session followed by five parallel tracks:
• 9th Stem Cell Research and Therapeutics Conference;
• 7th Assay and Drug Discovery Technologies Conference;
• 4th Translational Medicine Conference;
• 3rd Pharmacokinetics and Pharmacodynamics Conference;
• Biotechnology Transfer and Commercialization Conference.

For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


John C. McKew at NCATS, NIH to Speak at 8th Modern Drug Summit October 24-26 in Philadelphia, Pennsylvania

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Profile / Press Room |
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)